These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1985691)

  • 1. Reduction of graft failure by a monoclonal antibody (anti-LFA-1 CD11a) after HLA nonidentical bone marrow transplantation in children with immunodeficiencies, osteopetrosis, and Fanconi's anemia: a European Group for Immunodeficiency/European Group for Bone Marrow Transplantation report.
    Fischer A; Friedrich W; Fasth A; Blanche S; Le Deist F; Girault D; Veber F; Vossen J; Lopez M; Griscelli C
    Blood; 1991 Jan; 77(2):249-56. PubMed ID: 1985691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N; Le Deist F; Cant A; De Graeff-Meeders ER; Fasth A; Morgan G; Vellodi A; Hale G; Bujan W; Thomas C; Cavazzana-Calvo M; Wijdenes J; Fischer A
    Pediatrics; 1996 Sep; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone-marrow transplantation for immunodeficiencies and osteopetrosis: European survey, 1968-1985.
    Fischer A; Griscelli C; Friedrich W; Kubanek B; Levinsky R; Morgan G; Vossen J; Wagemaker G; Landais P
    Lancet; 1986 Nov; 2(8515):1080-4. PubMed ID: 2877234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti-CD2 antibodies. Société Française de Greffe de Moelle Osseuse.
    Cavazzana-Calvo M; Bordigoni P; Michel G; Esperou H; Souillet G; Leblanc T; Stephan JL; Vannier JP; Mechinaud F; Reiffers J; Vilmer E; Landman-Parker J; Benkerrou M; Baruchel A; Pico J; Bernaudin F; Bergeron C; Plouvier E; Thomas C; Wijdenes J; Lacour B; Blanche S; Fischer A
    Br J Haematol; 1996 Apr; 93(1):131-8. PubMed ID: 8611446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo infusion of anti-LFA-1 and anti-CD2 antibodies prevents graft failure after HLA partially incompatible bone marrow transplantation in children with high risk acute lymphoblastic leukaemia.
    Cavazzana-Calvo M; Jabado N; Bordigoni P; Michel G; Haddad E; Mechinaud F; Landman-Parker J; Leblanc T; Plouvier E; Baruchel A; Stephan JL; Souillet G; Vilmer E; Wijdenes J; Le Deist F; Fischer A
    Leuk Lymphoma; 1997 Dec; 28(1-2):103-12. PubMed ID: 9498709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody T-cell-depleted HLA-haploidentical bone marrow transplantation for Wiskott-Aldrich syndrome.
    Rumelhart SL; Trigg ME; Horowitz SD; Hong R
    Blood; 1990 Feb; 75(4):1031-5. PubMed ID: 2302455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiency: a report from the European Group for BMT and the European Group for Immunodeficiency.
    Fischer A; Landais P; Friedrich W; Gerritsen B; Fasth A; Porta F; Vellodi A; Benkerrou M; Jais JP; Cavazzana-Calvo M
    Blood; 1994 Feb; 83(4):1149-54. PubMed ID: 8111055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of graft failure by an anti-HLFA-1 monoclonal antibody in HLA-mismatched bone-marrow transplantation.
    Fischer A; Griscelli C; Blanche S; Le Deist F; Veber F; Lopez M; Delaage M; Olive D; Mawas C; Janossy G
    Lancet; 1986 Nov; 2(8515):1058-61. PubMed ID: 2877223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of familial hemophagocytic lymphohistiocytosis with bone marrow transplantation from HLA genetically nonidentical donors.
    Jabado N; de Graeff-Meeder ER; Cavazzana-Calvo M; Haddad E; Le Deist F; Benkerrou M; Dufourcq R; Caillat S; Blanche S; Fischer A
    Blood; 1997 Dec; 90(12):4743-8. PubMed ID: 9389690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unrelated donor marrow transplantation for congenital immunodeficiency and metabolic disease: an update of the experience of the Japan Marrow Donor Program.
    Sakata N; Kawa K; Kato K; Yabe H; Yabe M; Nagasawa M; Mugishima H; Kigasawa H; Tsuchida M; Akiyama Y; Morisima Y; Kodera Y; Kato S
    Int J Hematol; 2004 Aug; 80(2):174-82. PubMed ID: 15481448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Umbilical cord blood transplantation in severe T-cell immunodeficiency disorders: two-year experience.
    Knutsen AP; Wall DA
    J Clin Immunol; 2000 Nov; 20(6):466-76. PubMed ID: 11202237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow transplantation for Fanconi's anaemia: the Hammersmith experience 1977-89.
    Hows JM; Chapple M; Marsh JC; Durrant S; Yin JL; Swirsky D; Gordon-Smith EC
    Bone Marrow Transplant; 1989 Nov; 4(6):629-34. PubMed ID: 2684308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo infusion of anti LFA-1 antibody in HLA non-identical bone marrow transplantation in children: serum concentrations and biological effects.
    Perez N; Le Deist F; Chatenoud L; Chanteloup N; Griscelli C; Fischer A
    Bone Marrow Transplant; 1989 Jul; 4(4):379-84. PubMed ID: 2673457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of immunologic functions after bone marrow transplantation in 33 patients with severe combined immunodeficiency.
    Wijnaendts L; Le Deist F; Griscelli C; Fischer A
    Blood; 1989 Nov; 74(6):2212-9. PubMed ID: 2804359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation for autosomal recessive osteopetrosis. A report from the Working Party on Inborn Errors of the European Bone Marrow Transplantation Group.
    Gerritsen EJ; Vossen JM; Fasth A; Friedrich W; Morgan G; Padmos A; Vellodi A; Porras O; O'Meara A; Porta F
    J Pediatr; 1994 Dec; 125(6 Pt 1):896-902. PubMed ID: 7996361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA non-identical T-cell-depleted bone marrow transplantation for primary immunodeficiency diseases.
    Giri N; Vowels M; Ziegler JB; Ford D; Lam-Po-Tang R
    Aust N Z J Med; 1994 Feb; 24(1):26-30. PubMed ID: 8002854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow transplantation in 26 patients with Wiskott-Aldrich syndrome from a single center.
    Ozsahin H; Le Deist F; Benkerrou M; Cavazzana-Calvo M; Gomez L; Griscelli C; Blanche S; Fischer A
    J Pediatr; 1996 Aug; 129(2):238-44. PubMed ID: 8765621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.
    Filipovich AH; Shapiro RS; Ramsay NK; Kim T; Blazar B; Kersey J; McGlave P
    Blood; 1992 Jul; 80(1):270-6. PubMed ID: 1611094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.